Close Menu

All Personal

The drug pipelines of pharmaceutical companies like AstraZeneca are full of therapeutics being developed for personalized medicine, writes Frank Vinluan at MedCity News. AstraZeneca's Steve Labkoff says that 65 percent of the company's pipeline is personalized medicine.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Bloomberg reports that the DNA-for-cash deal reported in Kentucky might be a more widespread scam.

St. Jude Children's Research Hospital scientists have treated infants with X-linked severe combined immunodeficiency using gene therapy in an early phase study.

St. Louis Public Radio reports that some African Americans are turning to DNA ancestry testing to help guide genealogical searches.

In Nature this week: a genomic analysis of the snailfish Pseudoliparis swirei, ancient DNA analysis gives insight into the introduction of farming to England, and more.